Anthropic has confidentially filed paperwork with the SEC to go public — but that is not the same as having an IPO date. On June 1, 2026, the company confirmed it submitted a draft S-1 registration statement, the standard first step toward a US listing. Reports point to a possible Nasdaq debut around October 2026 at a valuation approaching $965 billion, but Anthropic has not confirmed a date, a share price, or even that the IPO will happen at all.
Here's what's actually confirmed, what's being reported by outlets tracking the deal, and what's still pure speculation.
Has Anthropic filed for an IPO?
Yes — with an important asterisk. On June 1, 2026, Anthropic announced that it had confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission.
A confidential filing is real and legally meaningful, but narrower than what most people picture when they hear "IPO filing":
- It lets the SEC begin reviewing the company's financials and disclosures privately, before anything becomes public.
- It gives Anthropic the option to go public once that review wraps up — it does not commit the company to a date.
- The S-1 itself, including revenue detail, risk factors, and ownership structure, isn't visible on SEC EDGAR yet and won't be until closer to the actual roadshow.
- Anthropic's own language was deliberately hedged: the offering "will depend on market conditions and other factors," and the number of shares and price "have not yet been set."
So the honest framing: Anthropic has started the machinery that leads to an IPO, not scheduled one. Confidential filings can be withdrawn or paused if market conditions sour — plenty of companies have filed and then waited a year, or never listed at all.
What we know about timing & valuation
Timing. No official IPO date exists. What's circulating is reporting, not confirmation: multiple outlets covering the filing cite October 2026 as a plausible Nasdaq or NYSE listing window, and frame Anthropic as trying to list ahead of rival OpenAI, which is reportedly preparing its own confidential filing. Treat "October" as an informed guess based on typical S-1-to-listing timelines (often four to seven months), not a locked calendar date.
Valuation. Here the numbers are real, but they describe the private market, not the IPO. Anthropic's funding trajectory in 2026 has been extraordinary:
- A $30 billion Series G in February 2026 valued the company at roughly $380 billion.
- A $65 billion Series H-1 in May 2026 pushed that to approximately $965 billion — reportedly ahead of OpenAI's own ~$852 billion private valuation at the time.
- Reporting around the confidential filing has floated the idea of Anthropic debuting as the first AI company to cross a $1 trillion valuation on public markets.
None of that is an IPO price. Private valuations are set by negotiation between a company and a handful of investors; public IPO pricing comes later, closer to the listing, based on roadshow demand and banker input. The eventual IPO valuation commonly lands above, below, or roughly in line with the last private mark — there's no rule that it carries over. Anthropic's revenue growth is a big reason bankers are willing to float trillion-dollar numbers: annualized revenue reportedly jumped from around $10 billion a year prior to a run rate near $47 billion by mid-2026, even as the company still spends heavily on compute and isn't expected to turn profitable until 2028.
If you're tracking the money side of the AI industry more broadly, Wortins' funding tracker follows the rounds — like Anthropic's Series H-1 — that are shaping these valuations in real time.
Can you buy Anthropic stock?
Not yet, and not through any normal brokerage account. Anthropic remains a private company. There is no ticker, no listed shares, and no public market pricing its stock.
A few things worth knowing if you're seeing "buy Anthropic stock" content elsewhere:
- Secondary markets exist but are restricted. Shares in private AI companies sometimes change hands on platforms aimed at accredited or institutional investors, at prices those platforms set — this is not the same as buying on an exchange, and it carries liquidity and pricing risk retail investors don't usually deal with.
- Indirect exposure is possible but diluted. Some funds or vehicles claim exposure to Anthropic through private holdings; that's a very different risk profile than owning the stock directly.
- Watch for scams. Any offer to sell you "pre-IPO Anthropic shares" through an unverified platform or cold outreach should be treated with real suspicion. Legitimate pre-IPO access is limited to a small pool of institutional and strategic investors.
The only way to buy Anthropic stock in the normal sense is to wait for an actual public listing — which, as of this writing, has not happened and has no confirmed date.
Why it matters
Anthropic racing toward a public listing — possibly ahead of OpenAI, as our companion piece on the OpenAI IPO covers — would be one of the largest and most closely watched tech debuts ever, regardless of exactly when it lands or what it prices at. A few reasons this is worth tracking even in its current unresolved state:
- It would be a referendum on AI valuations. A trillion-dollar-plus public listing forces the broader market to publicly price in AI's future revenue, not just have private investors do it behind closed doors.
- It sets a template for the sector. How Anthropic's S-1 eventually discloses compute costs, customer concentration, and the path to profitability will shape how investors evaluate every other AI company that follows it to market, OpenAI included.
- The gap between "filed" and "trading" is where the real signal is. Confidential filings can stall, valuations can be repriced down before a roadshow, and market conditions between now and any actual listing can change fast. The interesting story over the next several months isn't the headline valuation — it's whether the filing keeps moving forward on schedule or slips.
Wortins will keep updating this page as the SEC review progresses and as Anthropic (or credible reporting) confirms real dates, pricing, or terms. Until shares are actually trading, everything else — including the numbers in this piece — should be read as "reported" or "expected," not settled fact.